Sfoglia per Relatore
Mostrati risultati da 1 a 9 di 9
Analisi della patologia e criticità nelle cure assistenziali in pazienti affetti da sindrome di leigh: case report
2021/2022 ROMANO, VITTORIA
At the crossroad between antitumor immunity and cancer metabolism: PD-L1 modulation by NAD+ and mTOR
2020/2021 MARINA, ELEONORA
In vitro evaluation of Nicotinamide Phosphoribosyltransferase (NAMPT) and mTOR pharmacological inhibition as prospective strategies for the treatment of BRAFi-resistant melanoma
2021/2022 CAUCINO, CHIARA
In vivo modeling of breast cancer initiation to study tumor immune evasion
2022/2023 MARINA, ELEONORA
Inhibition of glucose metabolism triggers targeted-therapy resistance in cultured BRAFV600E melanoma cells
2021/2022 BURRONE, GIULIA
Management infermieristico nell'impiego dell'immunoterapia per il trattamento del melanoma
2021/2022 REGGIANI, ARIANNA
Molecular mechanisms underlying BRAF inhibitors resistance in melanoma
2019/2020 CAUCINO, CHIARA
mTORC2 regulates BRAFV600E melanoma cells metabolism and sensitivity to BRAF inhibition
2019/2020 DIETRICH, ELISA
Sustained attenuation of RICTOR/mTORC2 functions promotes melanoma aggressiveness by paradoxical reactivation of Akt signaling.
2019/2020 BOTTINI, SVEVA
Mostrati risultati da 1 a 9 di 9
Legenda icone
- file disponibili solo agli amministratori
- nessun file disponibile